Celsius Named Needham’s Top Stock Pick for 2026
Needham names Celsius as a 2026 Top Pick, citing strong energy drink demand, expanded distribution, and a $70 price target.
Already have an account? Sign in.
Needham names Celsius as a 2026 Top Pick, citing strong energy drink demand, expanded distribution, and a $70 price target.
Bed Bath & Beyond beat forecasts, cut costs, improved sales, and is shifting from survival to growth with a leaner business model.
Angelini Pharma may buy Catalyst Pharmaceuticals. Talks are early, but news pushed Catalyst’s stock up. No deal is certain yet.
Starboard buys big stake in Flowserve, pushes for higher profits as AI boosts power demand; stock rises on growth hopes.